Shares of Colgate-Palmolive (NYSE:CL) have received an average recommendation of “Hold” from the nineteen brokerages that are covering the firm, MarketBeat.com reports. Four analysts have rated the stock with a sell recommendation, thirteen have assigned a hold recommendation and two have issued a buy recommendation on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $67.07.
A number of brokerages recently issued reports on CL. Stifel Nicolaus dropped their target price on shares of Colgate-Palmolive from $75.00 to $73.00 and set a “hold” rating on the stock in a research report on Monday, July 23rd. Wells Fargo & Co dropped their target price on shares of Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating on the stock in a research report on Wednesday, October 17th. Argus dropped their target price on shares of Colgate-Palmolive from $75.00 to $70.00 and set a “buy” rating on the stock in a research report on Tuesday, October 30th. ValuEngine raised shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a research report on Tuesday, July 31st. Finally, Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $65.00 to $60.00 and set a “hold” rating on the stock in a research report on Tuesday, October 30th.
In other news, VP Philip G. Shotts sold 17,000 shares of the business’s stock in a transaction on Tuesday, August 14th. The shares were sold at an average price of $65.44, for a total value of $1,112,480.00. Following the sale, the vice president now owns 49,949 shares in the company, valued at approximately $3,268,662.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Philip G. Shotts sold 462 shares of the business’s stock in a transaction on Tuesday, September 11th. The shares were sold at an average price of $67.05, for a total transaction of $30,977.10. Following the completion of the sale, the vice president now owns 41,250 shares in the company, valued at approximately $2,765,812.50. The disclosure for this sale can be found here. Insiders have sold 169,585 shares of company stock worth $11,132,140 in the last quarter. Corporate insiders own 1.02% of the company’s stock.
Shares of NYSE:CL traded down $0.56 during trading on Thursday, reaching $60.77. The stock had a trading volume of 3,299,436 shares, compared to its average volume of 5,894,941. Colgate-Palmolive has a 52 week low of $57.41 and a 52 week high of $77.91. The firm has a market cap of $52.48 billion, a price-to-earnings ratio of 21.17, a P/E/G ratio of 2.97 and a beta of 0.75. The company has a quick ratio of 0.77, a current ratio of 1.11 and a debt-to-equity ratio of 64.85.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, October 26th. The company reported $0.72 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The company had revenue of $3.85 billion for the quarter, compared to analyst estimates of $3.89 billion. During the same quarter last year, the firm posted $0.73 earnings per share. The company’s quarterly revenue was down 3.2% compared to the same quarter last year. Research analysts predict that Colgate-Palmolive will post 2.96 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 15th. Shareholders of record on Friday, October 19th will be paid a dividend of $0.42 per share. The ex-dividend date of this dividend is Thursday, October 18th. This represents a $1.68 dividend on an annualized basis and a yield of 2.76%. Colgate-Palmolive’s dividend payout ratio is currently 58.54%.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Featured Article: Asset Allocation and Your Retirement
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.